Sacituzumab Tirumotecan Extends Endometrial Cancer Survival
In endometrial cancer that has outlasted platinum chemotherapy and immunotherapy, a novel antibody–drug conjugate was pitted against doxorubicin or weekly paclitaxel.
Ähnliche Seiten
Immunotherapy Combo Shows Promise in Rectal Cancer